Funding Details
- Awarder
- Inbox
- Date Award
- December 01, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$13,000,000
Company Info
- Organizations Involved
- BioLife Solutions, Bristol Myers Squibb, Asahi Kasei, Charles River Laboratories
- Founders
- Rod Rietze, Ph.D
- Company Description
- IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.
- Market
- Gene Therapy
- Location
-
Worcester,
MA,
USA
- Coinvestors
- BioLife Solutions, Casdin Capital
Links